Last reviewed · How we verify
Spartalizumab in Pediatric cohort — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Spartalizumab in Pediatric cohort (Spartalizumab in Pediatric cohort) — University Hospital, Bordeaux.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Spartalizumab in Pediatric cohort TARGET | Spartalizumab in Pediatric cohort | University Hospital, Bordeaux | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Spartalizumab in Pediatric cohort CI watch — RSS
- Spartalizumab in Pediatric cohort CI watch — Atom
- Spartalizumab in Pediatric cohort CI watch — JSON
- Spartalizumab in Pediatric cohort alone — RSS
Cite this brief
Drug Landscape (2026). Spartalizumab in Pediatric cohort — Competitive Intelligence Brief. https://druglandscape.com/ci/spartalizumab-in-pediatric-cohort. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab